Dabigatran: potential higher risk of acute coronary event compared to other anticoagulants .
This report has been verified
by one or more authors of the
original publication.
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Dabigatran association with higher risk of acute coronary events: meta-analysis of noninferiority randomized controlled trials
Arch Intern Med. 2012 Mar 12;172(5):397-402. doi: 10.1001/archinternmed.2011.1666. Epub 2012 Jan 9In this meta-analysis, 7 studies (30,514 participants with atrial fibrillation (AF)) reporting the risk of developing myocardial infarction (MI) or acute coronary syndrome (ACS) from the use of dabigatran etexilate were evaluated. In comparison to warfarin, enoxaparin, or placebo, results indicated that dabigatran was associated with an increased risk of myocardial infarction (MI) and acute coronary syndrome (ACS).
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
